Yayın:
The use of a systems approach to increase NAD+ in human participants

dc.contributor.authorDianne Ford
dc.contributor.authorJohn Henderson
dc.contributor.authorSophia N. Z. Quigley
dc.contributor.authorShruti S. Chachra
dc.contributor.authorNichola J. Conlon
dc.contributor.orcid0000-0001-8121-9319
dc.contributor.orcid0000-0001-8546-1655
dc.contributor.orcid0009-0003-4548-2330
dc.date.accessioned2026-05-20T09:56:00Z
dc.date.issued2023-09-19
dc.identifier.doi10.21203/rs.3.rs-3306343/v1
dc.identifier.openalexW4386860869
dc.identifier.urihttps://hdl.handle.net/11421/39044
dc.identifier.urihttp://dx.doi.org/10.21203/rs.3.rs-3306343/v1
dc.language.isoen
dc.relation.ispartofResearch Square
dc.rightsopenAccess
dc.subjectNAD+ kinase
dc.subjectNicotinamide phosphoribosyltransferase
dc.subjectCrossover study
dc.subjectMedicine
dc.subjectGlycosylation
dc.subjectInternal medicine
dc.subjectImmunology
dc.subjectBiochemistry
dc.subjectChemistry
dc.subjectEnzyme
dc.subjectAlternative medicine
dc.titleThe use of a systems approach to increase NAD+ in human participants
dspace.entity.typePublication

Dosyalar

Koleksiyonlar